Now, the pioneering project is working toward completing its first livable housing complex. It will be fully bio-based, meaning all materials will ... Structures and Composites Center received $3.3 ...

CHICAGO -- An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and ...

The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...

While Judo Bio was preparing for its public launch, so was another siRNA start-up. City Therapeutics, the latest project of ...

The holy grail of marketing—not just in law but in every industry—is one-to-one engagement. Michael Idinopulos explores how ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

As global markets experience shifts, with small-cap indices like the Russell 2000 and S&P MidCap 400 outperforming, investors are increasingly turning their attention to smaller companies for ...

"Blood can be an extremely tough stain to remove because it is so complex," Romine says ... Enzymatic stain eliminators are formulated to treat bio-based stains like blood and other bodily fluids, ...

In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal ...